----item----
version: 1
id: {49C92D64-6E4A-4370-87F7-A157AE2A18EF}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/04/10/PharmAsia News Business Bulletin
parent: {01947E16-224D-4E59-9087-1F436747EC87}
name: PharmAsia News Business Bulletin
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 43cb4ea7-fa39-405b-8b36-4180f070e58a

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 77

{8B2376D2-D914-41D6-9402-D3CD38CABF23}|{07CF1C44-428A-445B-98D8-5EA9905BD7C5}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 3755

<p>A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.</p><p>Full stories can be accessed by clicking on the story title (subscription required).</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/7/blockbuster-patent-expiries-sparking-korean-generic-war" target="_new">Blockbuster Patent Expiries Sparking Korean Generic War</a></p><p>With patents for a series of global blockbuster drugs expiring this year, South Korean pharma firms are fiercely competing to grab bigger pieces of the domestic generic market. Amid an ongoing patent invalidation suit concerning BMS's Baraclude, Dong-A ST has been banned from producing and selling its generic version until the patent expires, while the Korean pharma association has warned its members against illegal rebates amid intensifying generic competition.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/7/interview-business-is-personal-for-avita-ceo-kelliher" target="_new">INTERVIEW: Business Is Personal For Avita CEO Kelliher</a></p><p>As a former war correspondent on the battlefields of the Balkans, Afghanistan and Iraq, new Avita Medical chief executive Adam Kelliher can claim to have an up-close understanding of the types of injuries that his regenerative medicine company's lead product is designed to heal.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/8/chinese-scientists-nobel-should-be-wakeup-call-insiders-say" target="_new">Chinese Scientist's Nobel Should Be Wakeup Call, Insiders Say</a></p><p>For a nation where millions of scientific students graduate each year but there have been no Nobel Prize winners in the sciences until this week, China gave surprisingly little recognition to its first Nobel Laureate in the area during her decades-long quest to develop a traditional herbal medicine into a global malaria treatment.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/7/asia-neglected-diseases-score-big-in-nobel-prize-win" target="_new">Asia, Neglected Diseases Score Big In Nobel Prize Win</a></p><p>Health campaigners and organizations working in the area of drugs for neglected diseases have hailed the Nobel Prize awarded to three researchers in the field, but the move also highlights shortcomings and research gaps.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/6/evogliptin-set-for-first-launch-in-crowded-korean-market" target="_new">Evogliptin Set For First Launch, In Crowded Korean Market</a></p><p>Dong-A ST's new type 2 diabetes therapy Suganon (evogliptin) has been approved in South Korea where it is set to compete with a number of already marketed DPP-4 inhibitors in an increasingly crowded sector. The domestic approval follows global licensing out deals for the drug in the past few years in other markets including China, India, Brazil and Russia.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/10/5/emerging-physician-groups-reshaping-china-healthcare-landscape" target="_new">Emerging Physician Groups Reshaping China Healthcare Landscape</a></p><p>From simply selling products to providing broad business solutions, medical device and service companies in China are now rushing to satisfy the needs of a rising tide of increasingly influential independent physician practice groups in China. Cloud-based diagnostic centers and specialist training are just some of the first steps, says one Chinese healthcare executive.</p><p><p>www.pharmasianews.com</p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 229

<p>A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150410T210724
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150410T210724
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150410T210724
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC030005
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

198800336
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{DB39CCA6-EB88-422C-8247-AB4AD01491E2}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

360808
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042503Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

43cb4ea7-fa39-405b-8b36-4180f070e58a
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042503Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
